Avantor (NYSE:AVTR – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.21 EPS for the quarter, beating analysts’ consensus estimates of $0.19 by $0.02, FiscalAI reports. The firm had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.61 billion. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. The firm’s revenue was up .5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.24 earnings per share. Avantor updated its FY 2026 guidance to 0.800-0.830 EPS.
Here are the key takeaways from Avantor’s conference call:
- Q2 results exceeded expectations, with revenue of $1.69 billion, adjusted EPS of $0.21, and $152 million in free cash flow excluding restructuring costs.
- VWR Distribution & Services returned to organic growth, up 1.7% year over year, supported by stronger large-customer execution, improved e-commerce performance, and increased pharma and biotech activity.
- Avantor raised its 2026 organic revenue growth outlook to -0.5% to 0.5% and adjusted EPS guidance to $0.80-$0.83, while expecting BMP to return to growth in the second half.
- Strong cash generation enabled $112 million of debt repayment during the quarter and nearly $500 million over the past 12 months; management remains committed to reducing adjusted net leverage below 3 times by year-end.
- BMP organic revenue declined 5.6% in Q2, while consolidated and segment margins faced lower volumes, inflation, freight costs, and unfavorable product mix; education and European demand also remained weaker than desired.
Avantor Stock Up 13.6%
NYSE AVTR traded up $1.70 during trading on Wednesday, reaching $14.12. The company’s stock had a trading volume of 22,321,042 shares, compared to its average volume of 10,680,044. The company has a current ratio of 1.76, a quick ratio of 1.17 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $9.64 billion, a PE ratio of -17.36, a PEG ratio of 6.55 and a beta of 0.94. Avantor has a 1-year low of $7.26 and a 1-year high of $15.93. The business has a 50-day moving average price of $9.89 and a 200-day moving average price of $9.39.
Insider Buying and Selling at Avantor
Hedge Funds Weigh In On Avantor
Several institutional investors have recently bought and sold shares of AVTR. Wellington Management Group LLP acquired a new stake in shares of Avantor in the fourth quarter worth about $268,584,000. Morgan Stanley increased its holdings in shares of Avantor by 179.4% during the 4th quarter. Morgan Stanley now owns 17,468,418 shares of the company’s stock valued at $200,188,000 after acquiring an additional 11,216,565 shares during the last quarter. Invesco Ltd. raised its stake in shares of Avantor by 7.0% in the 4th quarter. Invesco Ltd. now owns 17,178,716 shares of the company’s stock valued at $196,868,000 after acquiring an additional 1,125,348 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Avantor by 9.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 14,606,596 shares of the company’s stock valued at $167,392,000 after acquiring an additional 1,222,850 shares in the last quarter. Finally, Bank of America Corp DE lifted its holdings in Avantor by 122.0% in the 2nd quarter. Bank of America Corp DE now owns 7,495,095 shares of the company’s stock worth $100,884,000 after purchasing an additional 4,119,522 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on AVTR shares. Sanford C. Bernstein began coverage on shares of Avantor in a research report on Friday, June 26th. They issued a “market perform” rating and a $10.50 target price for the company. Evercore set a $10.50 price target on shares of Avantor in a report on Monday, July 6th. TD Cowen reaffirmed a “hold” rating on shares of Avantor in a research note on Wednesday, July 15th. Wolfe Research lowered Avantor to an “underperform” rating and set a $7.00 price objective for the company. in a report on Monday, June 1st. Finally, Wall Street Zen raised Avantor from a “hold” rating to a “buy” rating in a research report on Saturday, June 27th. Two equities research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Reduce” and an average target price of $10.62.
Read Our Latest Stock Report on Avantor
About Avantor
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
Read More
- Five stocks we like better than Avantor
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
- Meta’s AI Spending Problem Just Found a BlackRock Solution
- Broadcom’s $200 Billion Samsung Deal Shows How Costly the AI Memory Race Has Become
- 3 Refiners Benefiting From Oil Volatility and Tight Fuel Supply
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
